CHO-s

Increase viable CHO cell density by supplementation with recombinant Insulin Human AF

Increase viable CHO cell density by supplementation with recombinant Insulin Human AF

CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum to Serum free and further on to chemically defined media.

UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media under batch-mode culture resulted in significant increases in viable cell density, leading up to 53 % cell growth improvement and 66% of targeted protein production.

In addition to this benefit insulin has been proven to aid in the expression of difficult to express proteins.

You can read the full report behind the study or read the poster 

 

 

Contact

Sara Gualdoni

Product Manager

Email

Direct phone: +45 3199 5935